Fingerprint
Dive into the research topics of 'ERK2, but not ERK1, mediates acquired and "De novo" resistance to imatinib mesylate: Implication for CML therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
ERK2, but not ERK1, mediates acquired and "De novo" resistance to imatinib mesylate: Implication for CML therapy
Clara I. Aceves-Luquero, Anupriya Agarwal, Juan L. Calllejas-Valera, Laura Arias-González, Azucena Esparís-Ogando, Luis del Paso Ovalke, Itxaso Bellón-Echeverria, Miguel A. de la Cruz-Morcillo, Eva M.Galán Moya, Inmaculada Moreno Gimeno, Juan C. Gómez, Michael W. Deininger, Atanasio Pandiella, Ricardo Sánchez Prieto
Research output: Contribution to journal › Article › peer-review
40
Scopus
citations